tiprankstipranks
Advertisement
Advertisement

GLPG Stock Latest News

Galapagos price target lowered to $28 from $33 at RBC Capital
The FlyGalapagos price target lowered to $28 from $33 at RBC Capital
8d ago
GLPG
Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves
PremiumCompany Announcements
Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves
15d ago
6K
GLPG
Galapagos, Gilead enter pact to collaborate on T cell engager therapies
PremiumThe Fly
Galapagos, Gilead enter pact to collaborate on T cell engager therapies
15d ago
GILD
GLPG
Galapagos Files 2025 Annual Report and Calls April 28 Meetings on Rebranding and Share Buyback
PremiumCompany Announcements
Galapagos Files 2025 Annual Report and Calls April 28 Meetings on Rebranding and Share Buyback
16d ago
6K
GLPG
Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed
PremiumThe Fly
Galapagos chairman Jerome Contamine to step down, Gino Santini to succeed
20d ago
GLPG
Galapagos in partnership discussions with Gilead after Ouro deal
PremiumThe FlyGalapagos in partnership discussions with Gilead after Ouro deal
22d ago
GILD
GLPG
Galapagos Seeks Strategic Tie-Up With Gilead Around Ouro Medicines Deal and T Cell Engager OM336
Premium
Company Announcements
Galapagos Seeks Strategic Tie-Up With Gilead Around Ouro Medicines Deal and T Cell Engager OM336
22d ago
6K
GLPG
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
22d ago
GSK
GILD
Galapagos Discloses Bank of America’s Stake Drop Below 5% Threshold
PremiumCompany Announcements
Galapagos Discloses Bank of America’s Stake Drop Below 5% Threshold
29d ago
6K
GLPG
Galapagos Discloses Bank of America Crossing 5% Ownership Threshold in March 2026
PremiumCompany Announcements
Galapagos Discloses Bank of America Crossing 5% Ownership Threshold in March 2026
1M ago
6K
GLPG
Galapagos Launches Major 2026 Subscription Right Plan, Expanding Equity Incentive Pool
PremiumCompany Announcements
Galapagos Launches Major 2026 Subscription Right Plan, Expanding Equity Incentive Pool
1M ago
6K
GLPG
Galapagos Names New Chief HR Officer to Support Ongoing Corporate Transformation
PremiumCompany Announcements
Galapagos Names New Chief HR Officer to Support Ongoing Corporate Transformation
1M ago
6K
GLPG
Galapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
PremiumThe FlyGalapagos CHRO Annelies Missotten to step down, Tania Philipp to succeed
1M ago
VOR
GLPG
Galapagos Discloses Bank of America Crossing 5% Shareholding Threshold
Premium
Company Announcements
Galapagos Discloses Bank of America Crossing 5% Shareholding Threshold
1M ago
6K
GLPG
Galapagos NV Earnings Call: Cash Rich, In Transition
Premium
Company Announcements
Galapagos NV Earnings Call: Cash Rich, In Transition
2M ago
GLPG
Galapagos Posts 2025 Profit and Accelerates Strategic Exit from Cell Therapy
PremiumCompany Announcements
Galapagos Posts 2025 Profit and Accelerates Strategic Exit from Cell Therapy
2M ago
6K
GLPG
Is GLPG a Buy, Before Earnings?
PremiumPre-Earnings
Is GLPG a Buy, Before Earnings?
2M ago
GLPG
Galapagos Adds Industry Veteran Paulo Fontoura to Board as Independent Director
PremiumCompany Announcements
Galapagos Adds Industry Veteran Paulo Fontoura to Board as Independent Director
2M ago
6K
GLPG
Galapagos Discloses Bank of America Crossing 5% Voting Rights Threshold
PremiumCompany Announcements
Galapagos Discloses Bank of America Crossing 5% Voting Rights Threshold
2M ago
6K
GLPG
Galapagos to Wind Down Global Cell Therapy Operations and Close Five Sites
PremiumCompany AnnouncementsGalapagos to Wind Down Global Cell Therapy Operations and Close Five Sites
3M ago
6K
GLPG
Galapagos initiates the wind-down of cell therapy activities
Premium
The Fly
Galapagos initiates the wind-down of cell therapy activities
3M ago
GLPG
Galapagos Reports Mixed Late-Stage Results for TYK2 Inhibitor GLPG3667 and Eyes Partnerships After Dermatomyositis Win
Premium
Company Announcements
Galapagos Reports Mixed Late-Stage Results for TYK2 Inhibitor GLPG3667 and Eyes Partnerships After Dermatomyositis Win
4M ago
6K
GLPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >